Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Osilodrostat Phosphate Patent Expiration

Osilodrostat Phosphate is used for treating Cushing's disease. It was first introduced by Recordati Rare Diseases Inc in its drug Isturisa on Mar 6, 2020.


Osilodrostat Phosphate Patents

Given below is the list of patents protecting Osilodrostat Phosphate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Isturisa US10143680 Pharmaceutical dosage forms Jul 06, 2035 Recordati Rare
Isturisa US10709691 Pharmaceutical dosage forms Oct 12, 2035 Recordati Rare
Isturisa US8314097 Organic compounds Mar 27, 2029 Recordati Rare
Isturisa US8609862 Use of an adrenal hormone-modifying agent Jan 13, 2031 Recordati Rare
Isturisa US8835646 Organic compounds Aug 23, 2026 Recordati Rare
Isturisa US9434754 Use of an adrenal hormone-modifying agent Jan 13, 2031 Recordati Rare


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳